Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.
Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.
复制标题
DOI:
10.4049/jimmunol.2101170
复制
发表时间:
2022-06-01
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial hyperplasia and inflammation. The finding of autoantibodies in seropositive RA suggests that complement system activation might play a pathophysiologic role due to the local presence of immune complexes in the joints. Our first objective was to explore the Pathobiology of Early Arthritis Cohort (PEAC) mRNA sequencing data for correlations between clinical disease severity as measured by DAS28-ESR and complement system gene expression, both in the synovium and in blood. Our second objective was to determine the biodistribution using multiplex immunohistochemical (MIHC) staining of specific complement activation proteins and inhibitors from subjects in the Accelerating Medicines Partnership (AMP) RA/SLE study. In the PEAC study, there were significant positive correlations between specific complement gene mRNA expression levels in the synovium and DAS28-ESR for the following complement genes: C2, FCN1, FCN3, CFB, CFP, C3AR1, C5AR1, and CR1. Additionally, there were significant negative correlations between DAS28-ESR and Colec12, C5, C6, MASP-1, CFH and MCP. In the synovium there were also significant positive correlations between DAS28-ESR and FcγR1A, FcγR1B, FcγR2A and FcγR3A. Notably, CFHR4 synovial expression was positively correlated following treatment with the DAS28-ESR at six months, suggesting a role in worse therapeutic responses. The inverse correlation of C5 RNA expression in the synovium may underlie the failure of significant benefit from C5/C5aR inhibitors in clinical trials performed in patients with RA. MIHC analyses of Early RA synovium reveal significant evidence of regional alterations of activation and inhibitory factors that likely promote local complement activation.
登录
查看更多内容
影响因子:
--
作者:
Happonen KE;Saxne T;Aspberg A;Mörgelin M;Heinegård D;Blom AM
通讯作者:
Blom AM
DOI:
10.4049/jimmunol.1102310
发表时间:
2012-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Banda NK;Hyatt S;Antonioli AH;White JT;Glogowska M;Takahashi K;Merkel TJ;Stahl GL;Mueller-Ortiz S;Wetsel R;Arend WP;Holers VM
通讯作者:
Holers VM
影响因子:
--
作者:
Hootman, JM;Helmick, CG
通讯作者:
Helmick, CG
影响因子:
4.6
作者:
Banda, N. K.;Levitt, B.;Arend, W. P.
通讯作者:
Arend, W. P.
影响因子:
7.3
作者:
Holers VM;Banda NK
通讯作者:
Banda NK